These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
305 related articles for article (PubMed ID: 27844106)
1. Lymphoma: current status of clinical and preclinical imaging with radiolabeled antibodies. England CG; Rui L; Cai W Eur J Nucl Med Mol Imaging; 2017 Mar; 44(3):517-532. PubMed ID: 27844106 [TBL] [Abstract][Full Text] [Related]
2. Perspectives of molecular imaging and radioimmunotherapy in lymphoma. Iagaru A; Goris ML; Gambhir SS Radiol Clin North Am; 2008 Mar; 46(2):243-52, viii. PubMed ID: 18619379 [TBL] [Abstract][Full Text] [Related]
3. [Nuclear medicine and lymphoma]. Fernández de Sevilla Ribosa A Rev Esp Med Nucl; 2006; 25(2):77-9. PubMed ID: 16759612 [No Abstract] [Full Text] [Related]
6. Radioligand Therapy in Lymphoma: Past, Present, and Future. Almeida LS; Delgado Bolton RC; Heringer VC; de Souza Medina S; Etchebehere E PET Clin; 2024 Oct; 19(4):475-494. PubMed ID: 38969564 [TBL] [Abstract][Full Text] [Related]
7. Emerging role of immunoPET in receptor targeted cancer therapy. Marik J; Junutula JR Curr Drug Deliv; 2011 Jan; 8(1):70-8. PubMed ID: 21034420 [TBL] [Abstract][Full Text] [Related]
19. PET Imaging of Lung Cancers in Precision Medicine: Current Landscape and Future Perspective. Wang Q; Zhang X; Wei W; Cao M Mol Pharm; 2022 Oct; 19(10):3471-3483. PubMed ID: 35771950 [TBL] [Abstract][Full Text] [Related]
20. New insights into the mechanisms of action of radioimmunotherapy in lymphoma. Ivanov A; Swann R; Illidge T J Pharm Pharmacol; 2008 Aug; 60(8):987-98. PubMed ID: 18644192 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]